Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2021 17 2
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Hypericin Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021 8 0
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Jan/22/2021 8 0
Cyanidin-3-O-glucoside Potential treatment - pre-clinical evidence Natural product Antiviral Dec/08/2020 2 0
MB_241 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 1 0
MB_266 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 1 0
MB_250 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 1 0